[This corrects the article on p. 2797 in vol. 9, PMID: 31911863.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085860 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Correction: Prostate cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly.
Mol Cancer
September 2024
Obstetrics and Gynecology Hospital of Fudan University, State Key Lab of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Key Laboratory of Reproduction Regulation of NPFPC (SIPPR, IRD), Fudan University, Shanghai, 200438, People's Republic of China.
Corrigendum to "SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT Pathway" [Neoplasia (2021) 23, 1037-1047].
Neoplasia
September 2024
Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Electronic address:
Erratum: SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer.
Am J Cancer Res
November 2023
Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine Shanghai 200090, China.
[This corrects the article on p. 2797 in vol. 9, PMID: 31911863.
View Article and Find Full Text PDFPublisher Correction: Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3 E3 ligase in cancer cells.
Nat Commun
June 2022
Cancer Institute, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!